Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Latest
0.00%
↓ 100% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive growthDecelerating
Average
92.41%
Historical baseline
PeriodValue
20250.00%
2024-100.00%
2023-61.96%
2022-87.57%
20211253.88%
2020-80.24%
20190.00%
20180.00%
20170.00%
20160.00%